3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
45
INDUSTRY
21
NETWORK
16
NIH
9
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
6
Esophageal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Nasopharyngeal Carcinoma
5
Lung Neoplasms
5
Nasopharyngeal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Breast Neoplasms
3
Neoplasms, Germ Cell and Embryonal
2
Head and Neck Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Squamous Cell
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Recurrence
1
Ovarian Neoplasms
1
Oesophagogastric Cancer
1
Neoplasms, Squamous Cell
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Locally Advanced Cervical Carcinoma
1
Locally Advanced Cervical Cancer
1
Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
1
Gastro-enteropancreatic neuroendocrine tumor
1
Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement
1
Endometrial Neoplasms
1
EGFR Positive Non-small Cell Lung Cancer
1
Interventions
apatinib
3
pembrolizumab
2
Poly(ADP-ribose) Polymerase Inhibitors
2
Hyperthermic Intraperitoneal Chemotherapy
2
Bevacizumab
2
taxane
1
olaparib
1
lenvatinib
1
fludarabine
1
cediranib
1
Whole Genome Sequencing
1
Valproic Acid
1
Tranexamic Acid
1
Tai Ji
1
Surgical Procedures, Operative
1
Sequence Analysis, RNA
1
Saline Solution
1
Radiation
1
Qigong
1
Propranolol
1
Positron Emission Tomography Computed Tomography
1
Population Groups
1
Platinum
1
Paclitaxel
1
Neoadjuvant Therapy
1
Interleukin-2
1
Indocyanine Green
1
Immunohistochemistry
1
Hydralazine
1
Gene Expression
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Ovarian Neoplasms
×
Cisplatin
×
Clear all
NCT05827523
2026-02-13
FOCUS / KOV-04
National Cancer Center, Korea
Phase 3
Recruiting
520 enrolled